THE INTERACTION OF R(+)-AND S(-)-ZACOPRIDE WITH PCPA TO MODIFY RODENT AVERSIVE BEHAVIOR

被引:23
作者
BARNES, NM [1 ]
COSTALL, B [1 ]
GE, J [1 ]
KELLY, ME [1 ]
NAYLOR, RJ [1 ]
机构
[1] UNIV BRADFORD,SCH PHARM,POSTGRAD STUDIES PHARMACOL,BRADFORD BD7 1DP,W YORKSHIRE,ENGLAND
关键词
R(+)-ZACOPRIDE; S(-)-ZACOPRIDE; PARA-CHLOROPHENYLALANINE; AVERSIVE BEHAVIOR; (RAT); (MOUSE);
D O I
10.1016/0014-2999(92)90142-Q
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The interaction of R(+)- and S(-)zacopride (0.00001-10 mg/kg i.p.) with parachlorophenylalanine (PCPA, 3 day treatment 100 mg/kg i.p.) to modify behaviour in an aversive situation was investigated in thc mouse black and white test box and rat social interaction test. R(+)-Zacopride (but not S(-)zacopride) and PCPA had an anxiolytic profile of action to reduce aversive responding in both species. Their established anxiolytic profiles were abolished by a subsequent treatment with S(-)zacopride. In contrast, S(-)-zacopride was less or ineffective if administered simultaneously with R(+)-zacopride. A co-treatment of PCPA with R(+)-zacopride also inhibited thc anxiolytic profiles observed to thc individual treatments. It is concluded that there is a complex interaction between the isomers of zacopride to modify responding to an aversive situation that is dependent on thc temporal sequence of drug administration, and which may bc modified by changes in basal 5-hydroxytryptamine (5-HT) tone and agonist, partial agonist and antagonist effects at the 5-HT3 receptor.
引用
收藏
页码:15 / 25
页数:11
相关论文
共 33 条
[1]  
ANTON AH, 1962, J PHARMACOL EXP THER, V138, P360
[2]   AGONIST INTERACTIONS WITH 5-HT(3) RECEPTOR RECOGNITION SITES IN THE RAT ENTORHINAL CORTEX LABELED BY STRUCTURALLY DIVERSE RADIOLIGANDS [J].
BARNES, JM ;
BARNES, NM ;
COSTALL, B ;
JAGGER, SM ;
NAYLOR, RJ ;
ROBERTSON, DW ;
ROE, SY .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (02) :500-504
[3]   THE DIFFERENTIAL ACTIVITIES OF R(+)-ZACOPRIDE AND S(-)-ZACOPRIDE AS 5-HT3 RECEPTOR ANTAGONISTS [J].
BARNES, JM ;
BARNES, NM ;
COSTALL, B ;
DOMENEY, AM ;
JOHNSON, DN ;
KELLY, ME ;
MUNSON, HR ;
NAYLOR, RJ ;
YOUNG, R .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 37 (04) :717-727
[4]  
BILL DJ, 1991, BRIT J PHARMACOL, V104, P250
[5]  
BOCKAERT I, 1990, 2ND IUPHAR SAT M SER, P64
[6]   ZACOPRIDE AND BRL-24924 INDUCE AN INCREASE IN EEG-ENERGY IN RATS [J].
BODDEKE, HWGM ;
KALKMAN, HO .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (02) :281-284
[7]  
CHENG C H K, 1992, British Journal of Pharmacology, V105, p36P
[8]   ANIMAL-MODELS OF ANXIETY - THE EFFECT OF COMPOUNDS THAT MODIFY 5-HT NEUROTRANSMISSION [J].
CHOPIN, P ;
BRILEY, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (10) :383-388
[9]   EXPLORATION OF MICE IN A BLACK AND WHITE TEST BOX - VALIDATION AS A MODEL OF ANXIETY [J].
COSTALL, B ;
JONES, BJ ;
KELLY, ME ;
NAYLOR, RJ ;
TOMKINS, DM .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 32 (03) :777-785
[10]   ZACOPRIDE - ANXIOLYTIC PROFILE IN RODENT AND PRIMATE MODELS OF ANXIETY [J].
COSTALL, B ;
DOMENEY, AM ;
GERRARD, PA ;
KELLY, ME ;
NAYLOR, RJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (04) :302-305